Tresiba is a long-acting insulin prescribed to manage blood sugar levels in adults and children over 1 year old with type 1 and type 2 diabetes. The appropriate Tresiba dosage varies depending on ...

NovoLog is a mealtime (rapid-acting) insulin. It’s a brand-name form of insulin aspart. For type 1 diabetes, you’ll typically inject NovoLog before your meals throughout the day. For type 2 diabetes, ...

Patients with diabetes who use Abbott's FreeStyle Libre continuous glucose monitoring (CGM) systems can now better manage their blood glucose levels with a new method for leveraging the trend arrows ...

Basaglar (insulin glargine) is a brand-name drug that’s used to help manage blood sugar levels in certain people. The drug comes as a liquid solution that’s injected under your skin. It’s usually ...

The US Food and Drug Administration has cleared new decision-support software that aids in insulin dosing. In addition, Insulin Algorithms is "an affordable, easily adoptable tool for every-size ...

The FDA approves ALR Technologies' (OTCQB:ALRT) new insulin dose adjustment (IDA) feature on the ALRT diabetes management system for use by type 2 diabetics. The IDA uses ADA and AACE guidelines to ...

ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...

Insulin dosage is an ongoing area of interest among digital health companies. Initiating and increasing insulin dosages represent some of the greatest challenges to help Type 2 diabetes patients ...

(HealthDay News) — In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, insulin dose is not associated with cardiovascular (CV) death after adjustment for baseline covariates, ...

Treating people with Type 2 diabetes with a new once-a-week injectable insulin therapy proved to be safe and as effective as daily insulin injections, according to the results of two international ...